{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:00:17Z","timestamp":1792476017302,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCRD108-21"],"award-info":[{"award-number":["TCRD108-21"]}],"id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heart failure (HF) is a critical complication in elderly patients with atrial fibrillation (AF) and diabetes mellitus (DM). Recent preclinical studies suggested that non-vitamin K antagonist oral anticoagulants (NOACs) can potentially suppress the progression of cardiac fibrosis and ischemic cardiomyopathy. Whether different oral anticoagulants influence the risk of HF in older adults with AF and DM is unknown. This study aimed to evaluate the risk of HF in elderly patients with AF and DM who were administered NOACs or warfarin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A nationwide retrospective cohort study was conducted based on claims data from the entire Taiwanese population. Target trial emulation design was applied to strengthen causal inference using observational data. Patients aged \u2009\u2265\u200965\u00a0years with AF and DM on NOAC or warfarin treatment between 2012 and 2019 were included and followed up until 2020. The primary outcome was newly diagnosed HF. Propensity score-based fine stratification weightings were used to balance patient characteristics between NOAC and warfarin groups. Hazard ratios (HRs) were estimated using Cox proportional hazard models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study included a total of 24,835 individuals (19,710 NOAC and 5,125 warfarin users). Patients taking NOACs had a significantly lower risk of HF than those taking warfarin (HR\u2009=\u20090.80, 95% CI 0.74\u20130.86, p\u2009&lt;\u20090.001). Subgroup analyses for individual NOACs suggested that dabigatran (HR\u2009=\u20090.86, 95% CI 0.80\u20130.93, p\u2009&lt;\u20090.001), rivaroxaban (HR\u2009=\u20090.80, 95% CI 0.74\u20130.86, p\u2009&lt;\u20090.001), apixaban (HR\u2009=\u20090.78, 95% CI 0.68\u20130.90, p\u2009&lt;\u20090.001), and edoxaban (HR\u2009=\u20090.72, 95% CI 0.60\u20130.86, p\u2009&lt;\u20090.001) were associated with lower risks of HF than warfarin. The findings were consistent regardless of age and sex subgroups and were more prominent in those with high medication possession ratios. Several sensitivity analyses further supported the robustness of our findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This nationwide cohort study demonstrated that elderly patients with AF and DM taking NOACs had a lower risk of incident HF than those taking warfarin. Our findings suggested that NOACs may be the preferred oral anticoagulant treatment when considering the prevention of heart failure in this vulnerable population. Future research is warranted to elucidate causation and investigate the underlying mechanisms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-022-01688-1","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T16:09:04Z","timestamp":1673021344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Risk of heart failure in elderly patients with atrial fibrillation and diabetes taking different oral anticoagulants: a nationwide cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Shu-Man","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Pin-Sung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Chia-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jih-I","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif M.","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Chiung-Hui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hui","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"issue":"12","key":"1688_CR1","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.2337\/dc12-1801","volume":"35","author":"MS Kirkman","year":"2012","unstructured":"Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650\u201364.","journal-title":"Diabetes Care"},{"issue":"8","key":"1688_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837\u201347.","journal-title":"Circulation"},{"issue":"1","key":"1688_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7\u201311.","journal-title":"Card Fail Rev"},{"issue":"9","key":"1688_CR4","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.cjca.2016.05.005","volume":"32","author":"H Butrous","year":"2016","unstructured":"Butrous H, Hummel SL. Heart failure in older adults. Can J Cardiol. 2016;32(9):1140\u20137.","journal-title":"Can J Cardiol"},{"issue":"7","key":"1688_CR5","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","volume":"140","author":"SM Dunlay","year":"2019","unstructured":"Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, et al. Type 2 diabetes mellitus and heart failure: a scientific statement from the american heart association and the heart failure society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update. Circulation. 2019;140(7):e294\u2013324.","journal-title":"Circulation"},{"issue":"1","key":"1688_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-020-01109-1","volume":"19","author":"L Nesti","year":"2020","unstructured":"Nesti L, Pugliese NR, Sciuto P, Natali A. Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach. Cardiovasc Diabetol. 2020;19(1):134.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1688_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-021-01314-6","volume":"20","author":"L Nesti","year":"2021","unstructured":"Nesti L, Pugliese NR, Sciuto P, De Biase N, Mazzola M, Fabiani I, Trico D, Masi S, Natali A. Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes. Cardiovasc Diabetol. 2021;20(1):124.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1688_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ccl.2019.01.002","volume":"37","author":"H Sugumar","year":"2019","unstructured":"Sugumar H, Nanayakkara S, Prabhu S, Voskoboinik A, Kaye DM, Ling LH, Kistler PM. Pathophysiology of atrial fibrillation and heart failure: dangerous interactions. Cardiol Clin. 2019;37(2):131\u20138.","journal-title":"Cardiol Clin"},{"issue":"18","key":"1688_CR9","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","volume":"119","author":"E Anter","year":"2009","unstructured":"Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119(18):2516\u201325.","journal-title":"Circulation"},{"issue":"46","key":"1688_CR10","first-page":"3250","volume":"36","author":"D Kotecha","year":"2015","unstructured":"Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36(46):3250\u20137.","journal-title":"Eur Heart J"},{"issue":"5","key":"1688_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/STROKEAHA.116.016022","volume":"48","author":"K Adelborg","year":"2017","unstructured":"Adelborg K, Sz\u00e9pligeti S, Sundb\u00f8ll J, Horv\u00e1th-Puh\u00f3 E, Henderson VW, Ording A, Pedersen L, S\u00f8rensen HT. Risk of stroke in patients with heart failure: a population-based 30-year cohort study. Stroke. 2017;48(5):1161\u20138.","journal-title":"Stroke"},{"issue":"1","key":"1688_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","volume":"4","author":"MH Eckman","year":"2011","unstructured":"Eckman MH, Singer DE, Rosand J, Greenberg SM. Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2011;4(1):14\u201321.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"19","key":"1688_CR13","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/eurheartj\/ehy837","volume":"40","author":"TF Chao","year":"2019","unstructured":"Chao TF, Lip GYH, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, et al. Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities. Eur Heart J. 2019;40(19):1504\u201314.","journal-title":"Eur Heart J"},{"issue":"5","key":"1688_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"2","key":"1688_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/dom.14243","volume":"23","author":"HK Huang","year":"2021","unstructured":"Huang HK, Liu PP, Lin SM, Hsu JY, Peng CC, Munir KM, Wu TY, Yeh JI, Loh CH, Tu YK. Risk of developing diabetes in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants or warfarin: a nationwide cohort study. Diabetes Obes Metab. 2021;23(2):499\u2013507.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1688_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12933-021-01263-0","volume":"20","author":"CL Cheung","year":"2021","unstructured":"Cheung CL, Sing CW, Lau WCY, Li GHY, Lip GYH, Tan KCB, Cheung BMY, Chan EWY, Wong ICK. Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population-based cohort study. Cardiovasc Diabetol. 2021;20(1):71.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"1688_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.7326\/M21-3498","volume":"175","author":"HK Huang","year":"2022","unstructured":"Huang HK, Liu PP, Lin SM, Hsu JY, Yeh JI, Lai EC, Peng CC, Munir KM, Loh CH, Tu YK. Diabetes-related complications and mortality in patients with atrial fibrillation receiving different oral anticoagulants\u202f: a nationwide analysis. Ann Intern Med. 2022;175(4):490\u20138.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1688_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1160\/TH13-09-0730","volume":"111","author":"CT Esmon","year":"2014","unstructured":"Esmon CT. Targeting factor Xa and thrombin: impact on coagulation and beyond. Thromb Haemost. 2014;111(4):625\u201333.","journal-title":"Thromb Haemost"},{"issue":"8","key":"1688_CR19","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00380-019-01377-2","volume":"34","author":"Y Tsujino","year":"2019","unstructured":"Tsujino Y, Sakamoto T, Kinoshita K, Nakatani Y, Yamaguchi Y, Kataoka N, Nishida K, Kinugawa K. Edoxaban suppresses the progression of atrial fibrosis and atrial fibrillation in a canine congestive heart failure model. Heart Vessels. 2019;34(8):1381\u20138.","journal-title":"Heart Vessels"},{"issue":"10","key":"1688_CR20","doi-asserted-by":"publisher","first-page":"915","DOI":"10.5551\/jat.48405","volume":"26","author":"J Liu","year":"2019","unstructured":"Liu J, Nishida M, Inui H, Chang J, Zhu Y, Kanno K, Matsuda H, Sairyo M, Okada T, Nakaoka H, et al. Rivaroxaban suppresses the progression of ischemic cardiomyopathy in a murine model of diet-induced myocardial infarction. J Atheroscler Thromb. 2019;26(10):915\u201330.","journal-title":"J Atheroscler Thromb"},{"key":"1688_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, Lai EC. Taiwan\u2019s national health insurance research database: past and future. Clin Epidemiol. 2019;11:349\u201358.","journal-title":"Clin Epidemiol"},{"issue":"9","key":"1688_CR22","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","volume":"175","author":"AW Hsing","year":"2015","unstructured":"Hsing AW, Ioannidis JP. Nationwide population science: lessons from the Taiwan national health insurance research database. JAMA Intern Med. 2015;175(9):1527\u20139.","journal-title":"JAMA Intern Med"},{"issue":"15","key":"1688_CR23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMp2113319","volume":"385","author":"MA Hern\u00e1n","year":"2021","unstructured":"Hern\u00e1n MA. Methods of public health research\u2014strengthening causal inference from observational data. N Engl J Med. 2021;385(15):1345\u20138.","journal-title":"N Engl J Med"},{"issue":"9","key":"1688_CR24","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.cjca.2021.05.012","volume":"37","author":"SA Kutcher","year":"2021","unstructured":"Kutcher SA, Brophy JM, Banack HR, Kaufman JS, Samuel M. Emulating a randomised controlled trial with observational data: an introduction to the target trial framework. Can J Cardiol. 2021;37(9):1365\u201377.","journal-title":"Can J Cardiol"},{"issue":"13","key":"1688_CR25","doi-asserted-by":"publisher","first-page":"e017559","DOI":"10.1161\/JAHA.120.017559","volume":"9","author":"A Chen","year":"2020","unstructured":"Chen A, Stecker E, Warden BA. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13):e017559.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"1688_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"2","key":"1688_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"issue":"5","key":"1688_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/ageing\/afq059","volume":"39","author":"B Pamukcu","year":"2010","unstructured":"Pamukcu B, Lip GY, Lane DA. Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores. Age Ageing. 2010;39(5):533\u20135.","journal-title":"Age Ageing"},{"key":"1688_CR29","doi-asserted-by":"publisher","first-page":"l5657","DOI":"10.1136\/bmj.l5657","volume":"367","author":"RJ Desai","year":"2019","unstructured":"Desai RJ, Franklin JM. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ. 2019;367:l5657.","journal-title":"BMJ"},{"issue":"14","key":"1688_CR30","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/eurheartj\/ehr031","volume":"32","author":"G Heinze","year":"2011","unstructured":"Heinze G, J\u00fcni P. An overview of the objectives of and the approaches to propensity score analyses. Eur Heart J. 2011;32(14):1704\u20138.","journal-title":"Eur Heart J"},{"issue":"6","key":"1688_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601\u20139.","journal-title":"Circulation"},{"issue":"2","key":"1688_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/insr.12214","volume":"85","author":"PC Austin","year":"2017","unstructured":"Austin PC. A tutorial on multilevel survival analysis: methods models and applications. Int Stat Rev. 2017;85(2):185\u2013203.","journal-title":"Int Stat Rev"},{"issue":"11","key":"1688_CR33","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1177\/0962280220921889","volume":"29","author":"TA Balan","year":"2020","unstructured":"Balan TA, Putter H. A tutorial on frailty models. Stat Methods Med Res. 2020;29(11):3424\u201354.","journal-title":"Stat Methods Med Res"},{"issue":"8","key":"1688_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565\u201374.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"1688_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivariate Behav Res"},{"issue":"2","key":"1688_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150\u201361.","journal-title":"Pharm Stat"},{"issue":"2","key":"1688_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.15420\/ecr.2018.12.2","volume":"13","author":"J Gradol\u00ed","year":"2018","unstructured":"Gradol\u00ed J, Vidal V, Brady AJ, Facila L. Anticoagulation in patients with ischaemic heart disease and peripheral arterial disease: clinical implications of COMPASS study. Eur Cardiol. 2018;13(2):115\u20138.","journal-title":"Eur Cardiol"},{"issue":"Suppl B","key":"1688_CR38","doi-asserted-by":"publisher","first-page":"B84","DOI":"10.1093\/eurheartj\/suz003","volume":"21","author":"LA Ferri","year":"2019","unstructured":"Ferri LA, Bassanelli G, Savonitto S. Use of direct oral anticoagulant in ischaemic heart disease: the COMPASS study. Eur Heart J Suppl. 2019;21(Suppl B):B84-b87.","journal-title":"Eur Heart J Suppl"},{"issue":"9","key":"1688_CR39","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.2337\/dc10-0286","volume":"33","author":"JP van Melle","year":"2010","unstructured":"van Melle JP, Bot M, de Jonge P, de Boer RA, van Veldhuisen DJ, Whooley MA. Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the heart and soul study. Diabetes Care. 2010;33(9):2084\u20139.","journal-title":"Diabetes Care"},{"issue":"22","key":"1688_CR40","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","volume":"103","author":"C Iribarren","year":"2001","unstructured":"Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001;103(22):2668\u201373.","journal-title":"Circulation"},{"key":"1688_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diabres.2017.11.020","volume":"136","author":"Y Li","year":"2018","unstructured":"Li Y, Chen JP, Duan L, Li S. Effect of vitamin K2 on type 2 diabetes mellitus: a review. Diabetes Res Clin Pract. 2018;136:39\u201351.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7\u20138","key":"1688_CR42","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.nut.2016.01.011","volume":"32","author":"P Manna","year":"2016","unstructured":"Manna P, Kalita J. Beneficial role of vitamin K supplementation on insulin sensitivity, glucose metabolism, and the reduced risk of type 2 diabetes: a review. Nutrition. 2016;32(7\u20138):732\u20139.","journal-title":"Nutrition"},{"issue":"1","key":"1688_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/biof.1569","volume":"46","author":"N Karamzad","year":"2020","unstructured":"Karamzad N, Maleki V, Carson-Chahhoud K, Azizi S, Sahebkar A, Gargari BP. A systematic review on the mechanisms of vitamin K effects on the complications of diabetes and pre-diabetes. BioFactors. 2020;46(1):21\u201337.","journal-title":"BioFactors"},{"issue":"4","key":"1688_CR44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10741-018-9693-0","volume":"23","author":"L Zhao","year":"2018","unstructured":"Zhao L, Wang WYS, Yang X. Anticoagulation in atrial fibrillation with heart failure. Heart Fail Rev. 2018;23(4):563\u201371.","journal-title":"Heart Fail Rev"},{"key":"1688_CR45","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ijcard.2016.09.086","volume":"227","author":"LAE Brown","year":"2017","unstructured":"Brown LAE, Boos CJ. Atrial fibrillation and heart failure: factors influencing the choice of oral anticoagulant. Int J Cardiol. 2017;227:863\u20138.","journal-title":"Int J Cardiol"},{"issue":"5","key":"1688_CR46","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/oxfordjournals.aje.a112408","volume":"105","author":"KT Copeland","year":"1977","unstructured":"Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol. 1977;105(5):488\u201395.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"1688_CR47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/mpr.20","volume":"14","author":"M H\u00f6fler","year":"2005","unstructured":"H\u00f6fler M. The effect of misclassification on the estimation of association: a review. Int J Methods Psychiatr Res. 2005;14(2):92\u2013101.","journal-title":"Int J Methods Psychiatr Res"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01688-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T20:03:43Z","timestamp":1673121823000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01688-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1688"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01688-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"1 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Research Ethics Committee of Hualien Tzu Chi Hospital (REC No: IRB107-152-C); the requirement for informed consent was waived due to the retrospective use of anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that no competing interests exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}